Cambridge Healthtech Institute’s Second Annual

Executive Summit: Implementation Strategies for Digital Health

Commercialization, Regulatory and Partnering Strategies for Digital Health

June 2-4, 2020

TUESDAY, JUNE 2

7:30 am Registration and Morning Coffee

PLENARY SESSION: DIGITAL TRANSFORMATION IN HEALTHCARE

8:30 Chairperson’s Opening Remarks

8:35 Bringing Digital to Life: Transforming Healthcare and Patient Experience Using Human-Centered Design and Digital Solutions
Neil Gomes, MBA, Med, CSM, CSPO, Executive Vice President for Tech, Innovation & Consumer Experience, Enterprise Chief Digital Officer, Thomas Jefferson University & Jefferson Health
In this keynote presentation, Neil Gomes, Chief Digital Officer and EVP for Technology Innovation and Consumer Experience at Thomas Jefferson University and Jefferson Health, provides insights into how healthcare organizations can start to disrupt themselves by leveraging their experience in the industry to develop a better experience for their patients. This translates into developing not just digital health solutions, but creating new business models for healthcare that are focused on access, convenience, and experience; developing clinical processes that embrace the principles of human-centered design; and making strategic investments in developing a culture of continuous transformative innovation at healthcare organizations. With the insights and real-world examples that utilize modern technologies, such as artificial intelligence and machine learning, augmented and virtual reality, robotic process automation, dynamic decision systems, etc. that are part of this presentation, you will be able to embrace, define, and lead the consumer-focused, design-driven, and technology-enabled future of healthcare.

9:00 Driving Digital Transformation Success
Claus Jensen, PhD, Chief Digital Officer & Head of Technology, Memorial Sloan Kettering Cancer Center
While digital transformation is a hot topic in most organizations, statistics show that 9 out of 10 digital transformation initiatives actually fail to meet expectations – and the numbers having improved much since the emergence of Digital 2.0 imperatives. Join this session to discuss why digital transformation is so difficult, and what to do about it in order to improve your odds of success.

9:25 Delivering Digital Health in a Consumer Health World
Chet Robson, DO, MHCDS, FAAFP, Chief Clinical Officer, Walgreens
As patients take on more of the role of consumer, it is valuable to understand how consumers discover, navigate, choose, and utilize digital resources. This session explores how one retail healthcare company delivers digital assets for personal health, patient engagement, clinical research, and digital therapeutics.

9:50 Sponsored Presentation (Opportunity Available)

10:15 Coffee Break with Exhibit and Poster Viewing

11:00 The Future of Health Has Arrived: The Rise of Smart Health Communities
Asif Dhar, MD, MBA, Chief Health Informatics Officer, Principal, Deloitte Consulting LLP

11:25 Digital Health Is Here: How Will It Affect Your Health and the Health of Your Business?
Joseph C. Kvedar, MD, Professor, Dermatology, Harvard Medical School; Senior Advisor, Virtual Care, Partners HealthCare
The stark reality is that soon there will not be enough clinicians to care for our citizens sufficiently. Instead of relying on the more traditional and already overburdened one-to-one model, we must adopt technology that enables one-to-many care delivery models. In particular, artificial intelligence (AI) and other emerging technologies allow for outsourcing of routine tasks to machines, creating space in the schedule for human interaction between clinician and patient. How can we apply digital and telehealth to improve care delivery, patient and clinician satisfaction, and clinical outcomes?

11:50 PANEL DISCUSSION
Moderator: Neil Gomes, MBA, Med, CSM, CSPO, Executive Vice President, Tech, Innovation & Consumer Experience, Enterprise Chief Digital Officer, Thomas Jefferson University & Jefferson Health

Panelists to be Announced

12:30 pm Luncheon Presentation (Sponsorship Opportunity Available) or Enjoy Lunch on Your Own

1:00 Session Break

DIGITAL HEALTH AT BIG PHARMA

2:00 Chairperson’s Remarks

2:05 Presentation to be Announced

2:20 Presentation to be Announced

2:55 Sponsored Presentation (Opportunity Available)

3:10 PANEL DISCUSSION: What Is Big Pharma Strategy for Investing in and Implementing Digital Medicine?
Moderator: David Kim, Managing Director, DigiTx

4:00 Refreshment Break with Exhibit and Poster Viewing

PLENARY SESSION: BRIDGING SILOS: AN INTEGRATED APPROACH TO DIGITAL HEALTH

4:45 Chairperson’s Remarks

4:50 Commercialization, Regulatory and Partnering Strategies with Provider, Payers, Hub, Industry for Digital
Karan Arora, MBA, Chief Commercial Digital Officer, Global Vice President, AstraZeneca

5:15 Sponsored Presentation (Opportunity Available)

5:30 PANEL DISCUSSION: An Integrated Approach to Data Silos, Collaboration and Patient-Centricity

6:00 Welcome Networking Reception with Exhibit and Poster Viewing

7:00 Close of Day

7:00-9:30 Dinner Short Course (Separate registration required)

WEDNESDAY, JUNE 3

8:00 am Morning Coffee

PLENARY SESSION: DIGITAL HEALTH INNOVATION

8:30 PANEL DISCUSSION: Investing in Digital Health Innovation
Moderator: Lisa Suennen, Lead, Digital & Technology Group, Manatt Ventures; Managing Director, Manatt Health
Panelists: David Kim, Managing Director, DigiTx
Additional Panelists to be Announced

9:30 Coffee Break with Exhibit and Poster Viewing

10:15 Chairperson’s Remarks
Lisa Suennen, Lead, Digital & Technology Group, Manatt Ventures; Managing Director, Manatt Health

10:20 Delivering Global Comprehensive Virtual Care at Scale
Lewis Levy, MD, FACP, CMO, Teladoc

10:45 Presentation to be Announced

11:10 Presentation to be Announced

11:35 Sponsored Presentation (Opportunity Available)

12:00 am Luncheon Presentation (Sponsorship Opportunity Available) or Enjoy Lunch on Your Own

12:30 Session Break

ACHIEVING COMMERCIAL SUCCESS IN DIGITAL HEALTH: REIMBURSEMENT, REGULATORY, AND MARKET ACCESS STRATEGIES

1:25 Chairperson’s Remarks

1:30 Talk Title to be Announced
Andrew C. Fish, JD, Chief Strategy Officer, AdvaMed Center for Digital Health

1:55 Implementing Strategies for Corporate Development
Raj Pallapothu, Professor, University of Texas – Dallas & Digital Health Practice Leader
In the Digital Health industry, corporate development is very much needed at any life sciences enterprise to create and execute innovative strategies that will help the company harness its competitive advantage, and thereby improve the financial and operating performance.

2:20 Regulatory Considerations during Mobile Medical App Development for Commercial and Clinical Trial Use
Michael J. Benecky, PhD, Senior Director, Global Regulatory Affairs, Precision and Digital Medicine, GlaxoSmithKline
Mobile medical apps are defined as medical devices from their intended use shown through labeling claims, advertising materials, or oral or written statements. Mobile medical app regulation is health risk-based to balance patient safety and barriers to technological innovation. Medical-device patient risk analysis is a critical activity prior to inclusion of digital tools within clinical trials. Digital safety parameters include patient privacy, data cybersecurity, and clinical risk due to app/sensor malfunction.

2:45 Sponsored Presentation (Opportunity Available)

3:00 Refreshment Break with Exhibit and Poster Viewing

ACHIEVING COMMERCIAL SUCCESS IN DIGITAL HEALTH: REIMBURSEMENT, REGULATORY, AND MARKET ACCESS STRATEGIES (CONT.)

3:25 Chairperson’s Remarks

3:50 Market Access
Speaker to be Announced

4:15 Partnering Strategies
Speaker to be Announced

4:40 PANEL DISCUSSION: What Does It Take to Succeed as a Digital Health Company?

5:30 Close of Day and Registration for Short Course

6:00-9:00 Dinner Short Course (Separate registration required)

THURSDAY, JUNE 4

8:00 am Morning Coffee

AI IN HEALTHCARE: BUSINESS MODELS AND GROWTH OPPORTUNITIES

8:30 Chairperson’s Remarks

8:35 Emerging Patient-Centric Business Models for AI in Healthcare
Annastasiah Mudiwa Mhaka, PhD, Co-Founder, Convenor; President, Alliance for AI in Healthcare (AAIH)
The potential for AI in healthcare, while promising, is currently limited due to a lack of datasets of sufficient quality and size. Improving integrated longitudinal datasets will be critical for machine-learned biomedical discovery, clinical testing, and decision support in patient care and population health settings. The dialogue will cover how these limitations are beginning to impact business models across health systems, tech companies, AI platform developers, biopharma, patients, and consumers.

9:00 Sponsored Presentation (Opportunity Available)

9:15 PANEL DISCUSSION: Title to be Announced

10:05 Interactive Breakout Discussions Coffee Break

PLENARY SESSION: EVIDENCE-BASED DIGITAL MEDICINE

11:00 Chairperson’s Remarks

11:05 How Digital Health, Digital Medicine, and Digital Therapeutics Can Reshape Provider, Payer, Pharma, and Patient Collaboration
Ashish Atreja, MD, MPH, Assistant Professor, Chief Innovation Officer, Medicine, Icahn School of Medicine at Mount Sinai

11:30 Using Digital Solutions to Drive Real-World Research
Stella Safo, MD, MPH, Chief Clinical Transformation Officer, Vice President, Prospective Research, Premier, Inc.
This session will evaluate how digital solutions, from clinical decision support tools to population health performance management platforms, accelerate the breadth of insights that can be gleaned from real-world research studies.

11:55 PANEL DISCUSSION: Real World Impact of Digital Medicine
Moderator: Ashish Atreja, MD, MPH, Assistant Professor, Chief Innovation Officer, Medicine, Icahn School of Medicine at Mount Sinai

12:30 pm Close of Conference